Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
about
Impact of S100A4 Expression on Clinicopathological Characteristics and Prognosis in Pancreatic Cancer: A Meta-AnalysisA link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balanceS100 proteins in cancer.ELL targets c-Myc for proteasomal degradation and suppresses tumour growth.Cancer subclonal genetic architecture as a key to personalized medicine.Distinct prognostic values of S100 mRNA expression in breast cancer.Joining S100 proteins and migration: for better or for worse, in sickness and in health.RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integrationA generally applicable translational strategy identifies S100A4 as a candidate gene in allergy.S100A7: from mechanism to cancer therapy.Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties.
P2860
Q26768261-2895C6FA-BBD0-4337-8CD2-B5EE5E6E2480Q28306743-BD346D84-8C9F-475A-9536-B84AA3513AAFQ34560305-A46D3E82-BADD-4006-95B7-3228A69DEF0BQ35104378-D48AC3A7-25C1-4AA0-A063-969F63033676Q35206368-75C4D46A-DA3B-449B-A407-21186D7FF8C4Q35968349-9A5ECD57-9CF9-4AC5-B3D4-36B6E1F78A7FQ37448116-65EBBF25-9C55-4B66-A7C9-3A41321A0166Q37554595-775BC5D7-44D8-4778-81BF-73D658B56975Q38118075-A1AE915F-1546-4110-87FA-B8DA9AA657AAQ38982380-DA864B72-E9EB-4B6F-BFD3-CA3B14AA38F7Q41879186-0196F4AE-5A92-4D21-8988-84DA6A9FCF5FQ42112839-60119A33-2BD2-4594-8328-6BA53BA2E7C7Q47927472-8F66CB8C-99FE-4243-ACB5-3E7EA2D8A3EDQ54222467-6E1956DB-E59D-4BCE-B1F1-6C5A4DFBAC55Q55461236-57DF6CBA-301A-4DCC-9CF6-6DACD8D907A3
P2860
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
@en
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
@nl
type
label
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
@en
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
@nl
prefLabel
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
@en
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
@nl
P2093
P2860
P356
P1433
P1476
Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion
@en
P2093
Birgitte Grum-Schwensen
Eugene Lukanidin
Jörg Klingelhöfer
Mariam Grigorian
Noona Ambartsumian
Rikke Stagaard Petersen Knudsen
P2860
P304
P356
10.1593/NEO.121554
P50
P577
2012-12-01T00:00:00Z